Point-of-care (POC) Diagnostics Market to Exhibit a Decent CAGR of 7.3% and Hit USD 23.36 Billion by 2027; Launch of POC Lumella by DiabetOmics to Accelerate Business, states Fortune Business Insights™

Top Players Covered in the Point of Care Diagnostics Market Research Report Are F. Hoffmann-La Roche Ltd (Basel, Switzerland), Thermo Fisher Scientific Inc. (Massachusetts, U.S.), Abbott Laboratories (Illinois, U.S), Quest Diagnostics Incorporated (New Jersey, United States), BD (Franklin Lakes, U.S), bioMérieux SA (Marcy l'Etoile, France), Cardinal Health, Inc. (Ohio, U.S), Mesa Biotech (California, U.S), Cepheid (California, U.S), Trinity Biotech (Bray, Ireland), Quidel Corporation (San Diego, U.S.), Bio-Rad Laboratories Inc. (California, U.S) and other key market players


Pune, India, March 02, 2021 (GLOBE NEWSWIRE) -- The global point-of-care diagnostics market size is expected to reach USD 23.36 billion by 2027, exhibiting a CAGR of 7.3% during the forecast period. The growing acceptance of POC testing kits in the treatment of acute and chronic diseases will spur ruminative opportunities for the global market, states Fortune Business Insights, in a report, titled “Point-of-care (POC) Diagnostics Market Size, Share & COVID-19 Impact Analysis, By Product (Blood Glucose Monitoring, Infectious Diseases, Cardiometabolic Diseases, Pregnancy & Infertility Testing, Hematology Testing, and Others), By End User (Hospital Bedside, Physicians Office Lab, Urgent Care & Retail Clinics, and Homecare/Self-Testing), and Regional Forecast, 2020-2027.” The market size stood at USD 18.45 billion in 2019.

Notable Development:

June 2020: Celltrion Group announced the launch of the SARS-CoV-2 point-of-care antigen diagnostic kit. The new development will help the company increase its access to COVID-19 diagnosis management and treatment globally.

Request a Sample Copy of the Global Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/point-of-care-diagnostics-market-101072

Introduction of Advanced Testing Kits to Enhance Market Scope

 The growing cases of diseases such as diabetes, infectious disease, HIV, and others have urged pharmaceutical companies to introduce innovative testing kits, which, in turn, will enable the growth of the market. For instance, in June 2019, Abbott announced the release of the Afinion HbA1c Dx assay. This assay is the first of its kind point-of-care test that has been approved by the U.S FDA for the diagnosis of diabetes.

Moreover, in February 2019, DiabetOmics introduced the point-of-care test Lumella for the accurate diagnosis of preeclampsia in pregnant women. Hence, the continuous and persistent efforts of major companies for the development of advanced POC kits will simultaneously encourage the healthy growth of the market in the forthcoming years.

Click here to get the short-term and long-term impact of COVID-19 on this Market.

Please visit: https://www.fortunebusinessinsights.com/industry-reports/point-of-care-diagnostics-market-101072

Growing Adoption of POC solutions to Boost Market in North America 

The market size in North America stood at USD 6.65 billion in 2019. The growth in the region is attributed to the increasing adoption of advanced point of care diagnostics solutions for the detection of various infectious diseases. Moreover, the strategic partnerships and collaborations among major organizations will further aid the development of the market in North America.

For instance, in September 2020, a global partnership between World Health Organization (WHO), Africa Centers for Disease Control and Prevention (Africa CDC), the Bill & Melinda Gates Foundation, the Clinton Health Access Initiative (CHAI), the Foundation for Innovative New Diagnostics (FIND), and the Global Fund together announced to provide access to COVID-19 rapid test in the low and middle-income countries.

The market in Europe is expected to expand radically during the forecast period owing to its growing efforts of companies to provide advanced rapid diagnostic solutions. For instance, in November 2019, Linear Diagnostics received investments of $2.6 million and planned to collaborate with the University of Birmingham, the U.K. to develop an optical point-of-care diagnostic testing platform for sexually transmitted diseases.

Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/point-of-care-diagnostics-market-101072

The Report Lists the Key Companies in the Point-of-care (POC) Diagnostics Market:

  • F. Hoffmann-La Roche Ltd (Basel, Switzerland)
  • Thermo Fisher Scientific Inc. (Massachusetts, U.S.)
  • Abbott Laboratories (Illinois, U.S)
  • Quest Diagnostics Incorporated (New Jersey, United States)
  • BD (Franklin Lakes, U.S)
  • bioMérieux SA (Marcy l'Etoile, France)
  • Cardinal Health, Inc. (Ohio, U.S)
  • Mesa Biotech (California, U.S)
  • Cepheid (California, U.S)
  • Trinity Biotech (Bray, Ireland)
  • Quidel Corporation (San Diego, U.S.)
  • Bio-Rad Laboratories Inc. (California, U.S)
  • Other Players

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/point-of-care-diagnostics-market-101072

Detailed Table of Content:

  • Introduction
    • Market Scope
    • Market Segmentation
    • Market Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Prevalence of Key Disease Indications– For Key Country/Region
    • Technological Advancements in the Point-of-care (POC) Diagnostics
    • New Product Launch
    • Overview of Regulatory Scenario
    • Key Industry Developments - Mergers, Acquisitions, and Partnerships
    • Overview of COVID-19 Impact on POC Diagnostics Market
    • Major Factors Driving the Impact of COVID-19
    • Reimbursement Changes in Response to COVID-19 Impact
    • Opportunities Offered by the Impact of COVID-19
  • Global Point-of-care (POC) Diagnostics Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Product
      •  Blood Glucose Monitoring
      •  Infectious Diseases
      •  Cardiometabolic Diseases
      •  Pregnancy & Infertility Testing
      •  Hematology Testing
      •  Others
      • Others
    • Market Analysis, Insights and Forecast – By End User
      •  Hospital Bedside
      •  Physician’s Office Lab
      •  Urgent Care & Retail Clinics
      •  Homecare/Self-testing
    • Market Analysis, Insights and Forecast – By Geography
      •  North America
      •  Europe
      •  Asia Pacific
      •  Latin America
      •  Middle East & Africa

TOC Continued…!!

Have a Look at Related Reports:

Drug Eluting Stent Market Size, Share & Industry Analysis, By Type (Coronary Stenting, and Peripheral Stenting), By Scaffold (Cobalt-Chromium, Platinum-Chromium, Nitinol and Others), By Drug (Sirolimus, Paclitaxel, Zotarolimus, Everolimus and Others), By End User (Hospitals, and Specialty Clinics), and Regional Forecast, 2019-2026

E-prescribing Market Size, Share & Industry Analysis, By Delivery Mode (Web-based, On-premise), By Prescription Type (Controlled substance, Non controlled Substances) By End User (Hospitals, Physician's offices, Pharmacies) and Regional Forecast, 2019-2026

Insulin Pump Market Size, Share & Industry Analysis, By Product Type (Pumps (Tethered Pumps, Patch Pumps, and Others), and Consumables), By Disease Indication (Type 1 Diabetes and Type 2 Diabetes), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Stores), and Regional Forecast, 2020-2027

Home Infusion Therapy Market Size, Share & Covid-19 Impact Analysis, By Product (Devices, Drugs, and Services) By Indication (Anti-Infective, Chemotherapy, Hydration Therapy, Enteral Nutrition, Total Parenteral Nutrition, Immunoglobulin Therapy, and Others), and Regional Forecast, 2020-2027

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs